September DOL-Treasury Hearings on Options For Retirement Plans

By Doug Palmer Tens of billions of dollars of Chinese investment could flood into the United States in the next decade, creating a multitude of

By Steve Silberman Merck was in trouble. In 2002, the pharmaceutical giant was falling behind its rivals in sales. Even worse, patents on five blockbuster